Home › Small Cell Lung Cancer › South Carolina
Small Cell Lung Cancer clinical trials in South Carolina
7 studies for Small Cell Lung Cancer are looking for participants at sites in South Carolina.
Cities in South Carolina
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- Carolina Urologic Research Center, Myrtle Beach
- Parkway Surgery Center, Myrtle Beach
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT03460977Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- PRISMA Health/ITOR, Greenville
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05983432A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
- Carolina Blood and Cancer Care, Rock Hill
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07459634A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
- Medical University of South Carolina Hollings Cancer Center, Charleston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT06095505Phase 2 Study of Fingolimod in Lung Cancers
- Hollings Cancer Center at Medical University of South Carolina, Charleston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 30, 2026 · NCT06424067Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
- Saint Joseph's/Candler - Bluffton Campus, Bluffton
- Prisma Health Cancer Institute - Spartanburg, Boiling Springs
- Prisma Health Cancer Institute - Easley, Easley
- and 6 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 30, 2026 · NCT06769126A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 123, Charleston
- Research Site 108, Greenville
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 21, 2025 · NCT05914116From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.